Topics

Companies Related to "Antibiotic Resistant Superbugs Hitching Rides Australian Gulls" [Most Relevant Company Matches] RSS

13:36 EDT 24th August 2019 | BioPortfolio

Here are the most relevant search results for "Antibiotic Resistant Superbugs Hitching Rides Australian Gulls" found in our extensive corporate database of over 50,000 company records.

Showing "Antibiotic Resistant Superbugs Hitching Rides Australian Gulls" Companies 1–25 of 427

Relevant

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.The initial focus is to find a solution to th...


AdvanDx, Inc

AdvanDx announces that at the recent American Society for Microbiology (ASM) meeting in Orlando, Florida, EVIGENE™ kits for detecting specific antibiotic resistance, virulence, and toxicity markers such as methicillin-resistance, vancomycin-resistance, PVL and TSST-1 in Staphylococcus aureus and enterococci, were launched for research use only in the United States. EVIGENE was officially launch...

Microbiotix, Inc.

Microbiotix, Inc. is a privately held, product-focused biopharmaceutical company engaged in the research and development of novel small molecule, anti-infective drugs that address commercially significant medical markets. The company currently has four novel compound series in research and development. Microbiotix currently has in development MBX 500, the first antibiotic that targets the DNA po...


Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II many dreaded infectious diseases such as diphtheria, pneumonia, syphilis, and tuberculosis disappeared almost overnight. However all is not well with the antibiotics story. The bacterial pathogens are f...

Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to combat the increasing number of antibiotic-resistant infections worldwide. The Company has two short-term strategic objectives:To identify and formulate proprietary topical Phage preparations from dis...

Lakewood-Amedex Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

Lakewood-Amedex, Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

Berkley Equine & Cattle

Berkley Equine & Cattle is a division of Berkley Program Specialists (a Berkley Company), that offers a wide variety of specialized equine and cattle insurance products including equine mortality, cattle mortality, equine farm package policies, equine liability, guided trail rides and carriage/pony rides. For more information about the products and service...

Lysando AG

Lysando AG is a technology leader in the area of antimicrobial proteins. Since its foundation in 2009, the privately financed research company has done research on artificial designer proteins with a team of scientists in the town of Regensburg. Artilysin®s represent a revolutionary breakthrough in the battle against multi-resistant bacteria. With this ...

Arsanis Inc

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The company’s major focus is on life threatening infections that are caused by antibiotic resistant pathogens, occur in immune compromised patients or are associated with ...

Arsanis, Inc

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that: are caused by antibiotic resistant pathogens; occur in immune compromised patients; or are associated wit...

Arsanis Biosciences GmbH

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that are caused by antibiotic resistant pathogens, occur in immune compromised patients or are associated with ...

Destiny Pharma Ltd

Destiny Pharma is a UK based anti-infectives pharmaceutical company founded, in 1997, by pharma industry executives. The company has developed and patented a portfolio of novel drugs that have a completely different mode of action from conventional antibiotics. These compounds (codenamed XF Drugs) have been shown to work in such a way that minimizes the development of bacterial resistance to repea...

Arsanis, Inc.

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that: are caused by antibiotic resistant pathogens; occur in immune compromised patients; or are associated wit...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market potential, improve the quality of care, or have unmet needs. Fero’s initial focus is on diabetes. The Company has acquired the intellectual property and other exclusive world-wide rights related to...

The Australian Wine Research Institute

Established in 1955, The Australian Wine Research Institute is a private company limited by guarantee. The AWRI is owned by the Australian wine industry and is funded primarily by Australia's grapegrowers and winemakers who pay the Wine Grapes and Grape Research levies, distributed through their investment body the Grape and Wine Research and Development Corporation, with matching funds from the A...

Procarta Biosystems

Procarta Biosystems is developing a new class of DNA-based therapeuticals, snare™ antibacterials, capable of combating drug-resistant bacterial infections. snare™ antibacterials act on novel genomic targets by capturing key regulatory proteins to block essential bacterial genes and defeat infection. Procarta is creating an extensive pipeline to tackle some of the most challenging b...

UTILITY therapeutics Limited

UTILITY therapeutics is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development...

Mpex Pharmaceuticals

Mpex Pharmaceuticals is focused on the discovery and development of new anti-bacterial drugs that meet the growing clinical need created by multi-drug resistant bacterial pathogens. It is well documented that antibiotic resistance is a growing, serious problem in both the hospital and community setting. Mpex's approach is to improve the activity of existing antibiotics by utilizing methods and pot...

Australian Biotechnology Association Limited

The Australian Biotechnology Association is a national body of companies and individuals dedicated to the development and prosperity of the Australian biotechnology industry. It is the peak body for the Australian Biotechnology industry, and provides a ‘platform’ which brings together all the relevant players involved in the Australian biosciences community. Its mission is to facilita...

UTILITY therapeutics Ltd

UTILITY is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today.

NovaDigm Therapeutics

NovaDigm is developing innovative vaccines to protect patients from fungal and bacterial infections, which can be life-threatening and drug resistant. The Company’s founding scientists from the LA BioMed Institute at Harbor-UCLA Medical Center are recognized leaders in the field of infectious disease and the emerging threat of “superbugs.” N...

Dairy Farmers Limited

Australian Dairy Farmers Limited (ADF) is a not-for-profit company representing the interests of Australian dairy farmers.We are guardians of Australian dairy farming.We are a representative organisation through the affiliation of State dairy farmer organisations.We are the national voice of Australia's dairy farmers.

Helperby Therapeutics Ltd Helperby Therapeutics

Helperby is a biopharmaceutical company dedicated to developing the next generation of lifesaving antibiotics. Helperby’s unique antibiotic technology outsmarts highly resistant bacteria by combining new resistance breakers with old antibiotics to create a whole new generation of therapies. The Company was spun out of St George’s University Hospi...

Allecra Therapeutics GmbH

Allecra Therapeutics Allecra is a biopharmaceutical company established in 2013 focussed on the development of novel treatments to combat multi drug-resistant bacterial infections. Allecra’s Mission Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms thereby saving ...


More From BioPortfolio on "Antibiotic Resistant Superbugs Hitching Rides Australian Gulls"

Quick Search

Corporate Database Quicklinks